Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes. [electronic resource]
- The Journal of infectious diseases 07 2017
- S168-S175 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
1537-6613
10.1093/infdis/jix128 doi
Disease Outbreaks--prevention & control Global Health Humans Models, Biological Models, Statistical Poliomyelitis--epidemiology Poliovirus--immunology Poliovirus Vaccine, Oral--administration & dosage Risk Serogroup